Record Inversion Deal Shows Pfizer Unfazed By New Rules
U.S. pharmaceutical giant Pfizer is pushing forward with the largest tax inversion deal ever recorded, spotlighting the meager impact of recent efforts to close loopholes that allow companies to benefit from...To view the full article, register now.
Already a subscriber? Click here to view full article